Porth's Essentials of Pathophysiology, 4e

638

Kidney and Urinary Tract Function

U N I T 7

R E F E R E N C E S

20. Schena FP, Gesualdo L. Pathogenic mechanisms of diabetic nephropathy. J Am Soc Nephrol. 2005;16(Suppl 1):S30–S33. 21. Ramakrishnan K, Scheid D. Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician. 2005;71:933–942. 22. Colgan R, Williams M, Johnson JR. Diagnosis and treatment of acute pyelonephritis in women. Am Fam Physician. 2011;84(5):519–526. 23. Kelley CJ, Neilson EC. Tubulointerstitial diseases. In: Taal MW, Chertow GM, Marsten PA, et al. Brenner and Rector's the Kidney . Volume 2, 9th ed. Philadelphia, PA: Elsevier Saunders; 2012:1332–1355. 24. Naughton C. Drug-induced nephrotoxicity. Am Fam Physician. 2008;78(6):743–750. 25. Taber SS, Mueller BA. Drug-associated renal dysfunction. Crit Care Clin 2006;22:357–374. 26. Blowey DL. Nephrotoxicity of over-the-counter analgesics, natural medicines, and illicit drugs. Adolesc Med 2005;16: 31–43. 27. Tanagho EA, Lue TF. Urinary obstruction and stasis. In: McAninch JW, Lue TF, eds. Smith & Tanagho's General Urology . 18th ed. New York, NY: McGraw-Hill Medical; 2013:170–181. 28. Stoller ML. Urinary stone disease. In: Tanagho EA, McAninch JW, eds. Smith’s General Urology . 17th ed. New York, NY: McGraw-Hill Medical; 2008:256–290. 29. Miller NL, Evan AP, Lingeman JE. Pathogenesis of renal calculi. Urol Clin North Am. 2007;34:295–313. 30. Moe OW. Kidney stones: pathophysiology and medical management. Lancet. 2006;367:333–444. 31. Frassetto L, Kohlstadt I. Treatment and prevention of kidney stones: an update. Am Fam Physician. 2011;84:1234–1242. 32. Anderson PM, Dhamne CA, Huff V. Wilms tumor. In: Kliegman RM, Statten BF, St. Gemell JW, et al., eds. Kliegman & Nelson Textbook of Pediatrics . 19th ed. Philadelphia, PA: Saunders Elsevier; 2011:1757–1860. 33. Rini BI, Campbell SC, Escudler B. Renal cell cancer. Lancet. 2009;3669(28):1119–1132. 34. Cohen HT, McGovern FJ. Renal cell carcinoma. N Engl J Med. 2005;353:2477–2490. 35. Wood LS. Renal cell carcinoma, screening, diagnosis, and prognosis. Clin J Oncol Nurs. 2009;13(6 Suppl):3–7.

1. Moore KL, Persaud TVN, Torchia MG. The Developing Human: Clinically Oriented Embryology . 9th ed. Philadelphia, PA: Elsevier Saunders; 2013:245–288. 2. Elder JS. Urologic disorders in infants and children. In: Kliegman RM, Statten BF, St. Gemell JW, et al., eds. Kliegman & Nelson Textbook of Pediatrics . 19th ed. Philadelphia, PA: Saunders Elsevier; 2011:1827–1829. 3. Sanna-Cherchi S, Caridi G, Weng PL. Genetic approaches to human renal agenesis/hypogenesis and dysplasia. Pediatr Nephrol 2007;22:1675–1684. 4. Jennette JC. The kidney. In: Rubin R, Strayer DS, eds. Rubin’s Pathology: Clinicopathologic Foundations of Medicine . 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012:753–807. 5. Alpers CE. The kidney. In: Kumar V, Abbas AK, Fautso N, et al. Robbins and Cotran Pathologic Basis of Disease . 8th ed. Philadelphia, PA: Saunders Elsevier; 2010:905–969. 6. Braun WE. Autosomal dominant polycystic kidney disease: emerging concepts of pathogenesis and new treatments. Cleve Clin J Med. 2009;76(2):97–104. 7. Wilson PD. Polycystic kidney disease. N Engl J Med 2004;350:151–164. 8. Gantham JJ. Autosomal dominant polycystic kidney disease. N Engl J Med. 2008;359(14):1477–1485. 9. Takier V, Caplan MJ. Polycystic kidney disease: Pathogenesis and potential treatment. Biochim Biophys Acta. 2011;1812(10):1337–1343. 10. Nachman PH, Jennette C, Falk FJ. Primary glomerular disease. In: Taal MW, Chertow GM, Marsten PA, et al. Brenner and Rector's The Kidney . Volume 2, 9th ed. Philadelphia, PA: Elsevier Saunders; 2012:1100–1191. 11. Thurman JM, Goldberg R. The glomerulopathies. In: Schrier RW, ed. Renal and Electrolyte Disorders . 7th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:559–607. 12. Chadban SJ, Atkins RC. Glomerulonephritis. Lancet 2005;365:1797–1806. 13. Beck LH, Salant DJ. Glomerular and tubulointerstitial diseases. Prim Care Clin North Am. 2008;35:265–296. 14. Rodriguez-Iturbe B, Musser JM. The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol. 2008;19:1855–1864. 15. D'Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulonephritis. N Engl J Med. 2011;365(24):2398–2411. 16. Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368(25):2402–2414. 17. Baratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol 2005;16:2088–2097. 18. Appel GB. New and future therapies for lupus nephritis. Cleve Clin J Med. 2012;79(2):134–140. 19. Ritz E. Clinical manifestations and natural history of diabetic kidney disease. Med Clin North Am. 2013;97:10–29.

Porth Essentials Resources Explore these additional resources to enhance learning for this chapter:

•  NCLEX-Style Questions and Other Resources on

, http://thePoint.lww.com/PorthEssentials4e

• Study Guide for Essentials of Pathophysiology • Adaptive Learning | Powered by PrepU, http://thepoint.lww.com/ prepu